HMOX1
protein-codingheme oxygenase 1
Gene summary
Heme oxygenase, an essential enzyme in heme catabolism, cleaves heme to form biliverdin, which is subsequently converted to bilirubin by biliverdin reductase, and carbon monoxide, a putative neurotransmitter. Heme oxygenase activity is induced by its substrate heme and by various nonheme substances. Heme oxygenase occurs as 2 isozymes, an inducible heme oxygenase-1 and a constitutive heme oxygenase-2. HMOX1 and HMOX2 belong to the heme oxygenase family. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~13.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013536
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013536
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013536
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013536
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013536
Submitter: ClinGen
HMOX1 was first reported in relation to autosomal recessive heme oxygenase deficiency in 1999 (Yachie et al., PMID: 9884342). The primary features of this condition include recurrent fever, hemolytic anemia, low serum bilirubin, elevated serum ferritin, and small or absent spleen. The underlying mechanism is a loss of heme oxidase activity leading to increased susceptibility to oxidative damage (PMID: 20055707). Six variants (nonsense, frameshift, splice site, whole exon deletion) that have been reported in five probands in five publications (PMIDs: 9884342; 210818618; 26526137; 32587840; 33066778) are included in this curation. Co-segregation with disease has not been observed. The mechanism of pathogenicity is biallelic loss of function. This gene-disease association is also supported by the known biological function of HMOX1, its expression pattern, functional alterations in patient and non-patient cells, and a non-human animal model (PMIDs: 9380735; 9380736; 9884342; 20055707; 25613900). In summary, HMOX1 is definitively associated with autosomal recessive heme oxygenase deficiency 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time without the emergence of contradictory evidence. This classification was approved by the ClinGen General Inborn Errors of Metabolism GCEP on 12/18/2023 (SOP Version 10).
Inheritance Pattern: Unknown
Disease ID:MONDO:0005002
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009061
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Craniofacial; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Renal
Intervention: Allergy/Immunology/Infectious; Hematologic
Rationale: Although the disease may ultimately be fatal, the condition includes immunodeficiency (includind due to asplenia), and prophylaxis and prompt and aggressive treatment of infections may be beneficial; RBC transfusions may be indicated for anemia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HMOX1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002133.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 122 | 123 | |||
| missense | 1 | 1 | 95 | 5 | 2 | 104 |
| nonsense | 7 | 2 | 9 | |||
| start loss | 0 | |||||
| frameshift | 9 | 2 | 11 | |||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 4 | |||
| Total | 18 | 8 | 96 | 127 | 2 | 251 |
Highest pathogenic variant AF is 0.0000514221
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002124.1 | 5 | MANE Select | |
| Ensembl | ENSP00000216117.8 | 5 | MANE Select | |
| Ensembl | ENSP00000413316.1 | 3 | Standard | |
| Ensembl | ENSP00000503987.1 | 2 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| hmox1a | Danio rerio | Structure: cardiac ventricle Quality: increased volume abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- HIF-1 signaling pathway - Homo sapiens (human)
- Hepatocellular carcinoma - Homo sapiens (human)
- Fluid shear stress and atherosclerosis - Homo sapiens (human)
- Porphyrin and chlorophyll metabolism - Homo sapiens (human)
- Mineral absorption - Homo sapiens (human)
Biological Process
- angiogenesis
- endothelial cell proliferation
- wound healing involved in inflammatory response
- negative regulation of leukocyte migration
- heme oxidation
Molecular Function
- heme oxygenase (decyclizing) activity
- phospholipase D activity
- protein binding
- enzyme binding
- heme binding
Cellular Component
- extracellular space
- nucleus
- nucleolus
- endoplasmic reticulum
- endoplasmic reticulum membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000216117
- Coding exons
- 5
- Length
- 13854
- Individuals with no LoFs
- 125726
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 22
- Defined
- 125748
- p
- 0.0000875
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.520 | 190 | 171 | 1.11 | 0.0000111 | 1860 |
| Missense (PolyPhen) | 63 | 53.113 | 1.1862 | 663 | ||
| Synonymous | -0.955 | 79 | 68.9 | 1.15 | 0.00000400 | 595 |
| Loss of Function | 1.75 | 5 | 11.3 | 0.441 | 5.84e-7 | 126 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000059 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00017 | 0.00017 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliverdin. Biliverdin is subsequently converted to bilirubin by biliverdin reductase. Under physiological conditions, the activity of heme oxygenase is highest in the spleen, where senescent erythrocytes are sequestrated and destroyed. Exhibits cytoprotective effects since excess of free heme sensitizes cells to undergo apoptosis.;
- Disease
- DISEASE: Heme oxygenase 1 deficiency (HMOX1D) [MIM:614034]: A disease characterized by impaired stress hematopoiesis, resulting in marked erythrocyte fragmentation and intravascular hemolysis, coagulation abnormalities, endothelial damage, and iron deposition in renal and hepatic tissues. Clinical features include persistent hemolytic anemia, asplenia, nephritis, generalized erythematous rash, growth retardation and hepatomegaly. {ECO:0000269|PubMed:9884342}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.862
Intolerance Scores
- LoFtool
- 0.611
- RVIS EVS
- -0.6
- RVIS percentile EVS
- 17.91
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.999
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |